GSK announces in the United Kingdom the investment of drugs in the United States of $ 30 billion, amid Trump’s government visit

Britain GSK On Wednesday, it became the latest pharmaceutical company to commit bumper investments in the United States, as President Donald Trump is in the UK visiting the state for three days.

The pharmaceutical maker is committed to investing at least $ 30 billion in research and development (R&D) and manufacturing over the next five years.

The drug maker said that the investment includes $ 1.2 billion towards advanced manufacturing, artificial intelligence and advanced digital technologies to present “pharmaceutical factories and laboratories from the next generation in the United States.”

The investment commitment comes at a time when President Donald Trump is in the United Kingdom to visit the state for three days.

“The country’s visit to this week brings together two countries that led the world to innovate science and health care. We are proud to be part of both,” said Emma and Al -Mili, CEO of GSK in a statement.

She added: “Today, we are committed to investing at least 30 billion dollars in the United States over the next five years, which increased the strengthening of the already strong research and development chain and the supply chain we have in the country.”

A number of international pharmaceutical companies intensified their American investments amid pressure from the Trump administration to enhance American manufacturing and reduce local drugs.

Astrazneca announced in July, plans for investment 50 billion dollars In the category and research capabilities in the United States by 2030, after a large number of obligations from companies, including Novartisand Sanovi and RushUK -based Eli Lily and Johnson and Johnson.

The company said that GSK’s commitment of $ 1.2 billion to advanced manufacturing is scheduled to include the construction of a new biology factory in Pennsylvania to produce respiratory drugs and cancer, in addition to adding advanced digital technology capabilities through the five industrial sites in Pennsylvania in Pennsylvania, North Marolina, Marolina, and Montana.

She added that the broader financing is scheduled to go towards capital investments through the American supply chain in GSK and increase investment in the discovery of medicines in research, development and clinical experience.

It turns out that Trump’s visit is the state ProfitableWith a number of companies including Microsoftand Nafidiaand GoogleAnd Openai and Salesforce This week, artificial intelligence investments in the UK announced this week with a reinforced via relations.

This is a developing story. Please check again for updates.